Pacer Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,649
| Closed | -$16.4K | – | 2553 |
|
|
2024
Q2 | $16.4K | Sell |
2,649
-4,657
| -64% | -$28.8K | ﹤0.01% | 3443 |
|
|
2024
Q1 | $37.1K | Buy |
+7,306
| New | +$37.1K | ﹤0.01% | 3291 |
|
|
2021
Q2 | – | Sell |
-6,177
| Closed | -$63K | – | 1424 |
|
|
2021
Q1 | $63K | Sell |
6,177
-9,768
| -61% | -$99.6K | ﹤0.01% | 1408 |
|
|
2020
Q4 | $119K | Sell |
15,945
-8,558
| -35% | -$63.9K | ﹤0.01% | 1336 |
|
|
2020
Q3 | $84K | Buy |
+24,503
| New | +$84K | ﹤0.01% | 1274 |
|
|
2018
Q4 | – | Sell |
-7,158
| Closed | -$55K | – | 581 |
|
|
2018
Q3 | $55K | Buy |
+7,158
| New | +$55K | ﹤0.01% | 1139 |
|
|
2018
Q1 | – | Sell |
-2,100
| Closed | -$10K | – | 1045 |
|
|
2017
Q4 | $10K | Buy |
+2,100
| New | +$10K | ﹤0.01% | 1142 |
|